Titre : Comptes-rendus de sortie des patients

Comptes-rendus de sortie des patients : Questions médicales fréquentes

Termes MeSH sélectionnés :

Early Detection of Cancer
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Comptes-rendus de sortie des patients : Questions médicales les plus fréquentes", "headline": "Comptes-rendus de sortie des patients : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Comptes-rendus de sortie des patients : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-07-11", "dateModified": "2025-04-07", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Comptes-rendus de sortie des patients" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Dossiers médicaux", "url": "https://questionsmedicales.fr/mesh/D008499", "about": { "@type": "MedicalCondition", "name": "Dossiers médicaux", "code": { "@type": "MedicalCode", "code": "D008499", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.520.308.940.968" } } }, "about": { "@type": "MedicalCondition", "name": "Comptes-rendus de sortie des patients", "alternateName": "Patient Discharge Summaries", "code": { "@type": "MedicalCode", "code": "D063886", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Christine Maria Schwarz", "url": "https://questionsmedicales.fr/author/Christine%20Maria%20Schwarz", "affiliation": { "@type": "Organization", "name": "Research Unit for Safety and Sustainability in Healthcare, c/o, Division of Plastic, Aesthetic and Reconstructive Surgery, Department of Surgery , Medical University of Graz, Graz, Austria." } }, { "@type": "Person", "name": "Magdalena Hoffmann", "url": "https://questionsmedicales.fr/author/Magdalena%20Hoffmann", "affiliation": { "@type": "Organization", "name": "Research Unit for Safety and Sustainability in Healthcare, c/o, Division of Plastic, Aesthetic and Reconstructive Surgery, Department of Surgery , Medical University of Graz, Graz, Austria. magdalena.hoffmann@medunigraz.at." } }, { "@type": "Person", "name": "Gerald Sendlhofer", "url": "https://questionsmedicales.fr/author/Gerald%20Sendlhofer", "affiliation": { "@type": "Organization", "name": "Research Unit for Safety and Sustainability in Healthcare, c/o, Division of Plastic, Aesthetic and Reconstructive Surgery, Department of Surgery , Medical University of Graz, Graz, Austria." } }, { "@type": "Person", "name": "Thomas R Campion", "url": "https://questionsmedicales.fr/author/Thomas%20R%20Campion", "affiliation": { "@type": "Organization", "name": "Department of Population Health, Weill Cornell Medicine, New York, NY 10065, United States." } }, { "@type": "Person", "name": "Rebecca Brundin-Mather", "url": "https://questionsmedicales.fr/author/Rebecca%20Brundin-Mather", "affiliation": { "@type": "Organization", "name": "Department of Critical Care Medicine, University of Calgary, Calgary T2N 4Z6, Alberta, Canada." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "The role of diffusion magnetic resonance imaging in determining tumor aggressiveness during preoperative surgical planning in early-stage endometrial cancer.", "datePublished": "2023-04-04", "url": "https://questionsmedicales.fr/article/37014376", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00117-023-01134-7" } }, { "@type": "ScholarlyArticle", "name": "Survival and prognostic factors of early-stage non-small cell lung cancer in Central and Eastern Europe: A prospective cohort study.", "datePublished": "2023-03-23", "url": "https://questionsmedicales.fr/article/36952375", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/cam4.5791" } }, { "@type": "ScholarlyArticle", "name": "Immune checkpoints expression patterns in early-stage triple-negative breast cancer predict prognosis and remodel the tumor immune microenvironment.", "datePublished": "2023-02-06", "url": "https://questionsmedicales.fr/article/36814908", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fimmu.2023.1073550" } }, { "@type": "ScholarlyArticle", "name": "Meta-analysis of laparoscopic radical hysterectomy, excluding robotic assisted versus open radical hysterectomy for early stage cervical cancer.", "datePublished": "2023-01-06", "url": "https://questionsmedicales.fr/article/36609438", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41598-023-27430-9" } }, { "@type": "ScholarlyArticle", "name": "Feasibility of a lung airway navigation system using fiber-Bragg shape sensing and artificial intelligence for early diagnosis of lung cancer.", "datePublished": "2022-12-07", "url": "https://questionsmedicales.fr/article/36476838", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pone.0277938" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Environnement et santé publique", "item": "https://questionsmedicales.fr/mesh/D004778" }, { "@type": "ListItem", "position": 3, "name": "Santé publique", "item": "https://questionsmedicales.fr/mesh/D011634" }, { "@type": "ListItem", "position": 4, "name": "Méthodes épidémiologiques", "item": "https://questionsmedicales.fr/mesh/D004812" }, { "@type": "ListItem", "position": 5, "name": "Collecte de données", "item": "https://questionsmedicales.fr/mesh/D003625" }, { "@type": "ListItem", "position": 6, "name": "Documents", "item": "https://questionsmedicales.fr/mesh/D011996" }, { "@type": "ListItem", "position": 7, "name": "Dossiers médicaux", "item": "https://questionsmedicales.fr/mesh/D008499" }, { "@type": "ListItem", "position": 8, "name": "Comptes-rendus de sortie des patients", "item": "https://questionsmedicales.fr/mesh/D063886" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Comptes-rendus de sortie des patients - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Comptes-rendus de sortie des patients", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-06", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Comptes-rendus de sortie des patients", "description": "Quels diagnostics sont souvent notés dans un compte-rendu ?\nComment le diagnostic est-il confirmé dans le rapport ?\nQuelle est l'importance du diagnostic dans le compte-rendu ?\nLes diagnostics sont-ils classés dans le compte-rendu ?\nComment les diagnostics influencent-ils le traitement ?", "url": "https://questionsmedicales.fr/mesh/D063886?mesh_terms=Early+Detection+of+Cancer&page=1000#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Comptes-rendus de sortie des patients", "description": "Quels symptômes sont souvent mentionnés ?\nComment les symptômes sont-ils évalués ?\nLes symptômes changent-ils après le traitement ?\nLes symptômes sont-ils classés par gravité ?\nComment les symptômes influencent-ils le suivi ?", "url": "https://questionsmedicales.fr/mesh/D063886?mesh_terms=Early+Detection+of+Cancer&page=1000#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Comptes-rendus de sortie des patients", "description": "Quelles mesures préventives sont recommandées ?\nComment la prévention est-elle abordée dans le rapport ?\nLa prévention est-elle personnalisée ?\nQuels conseils de prévention sont souvent inclus ?\nLa prévention est-elle suivie après la sortie ?", "url": "https://questionsmedicales.fr/mesh/D063886?mesh_terms=Early+Detection+of+Cancer&page=1000#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Comptes-rendus de sortie des patients", "description": "Quels types de traitements sont documentés ?\nComment les traitements sont-ils justifiés ?\nLes traitements sont-ils suivis d'effets secondaires ?\nComment les traitements sont-ils planifiés ?\nLes traitements sont-ils adaptés après la sortie ?", "url": "https://questionsmedicales.fr/mesh/D063886?mesh_terms=Early+Detection+of+Cancer&page=1000#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Comptes-rendus de sortie des patients", "description": "Quelles complications peuvent survenir après la sortie ?\nComment les complications sont-elles signalées ?\nLes complications sont-elles documentées dans le rapport ?\nComment prévenir les complications après la sortie ?\nLes complications influencent-elles le suivi ?", "url": "https://questionsmedicales.fr/mesh/D063886?mesh_terms=Early+Detection+of+Cancer&page=1000#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Comptes-rendus de sortie des patients", "description": "Quels facteurs de risque sont souvent identifiés ?\nComment les facteurs de risque sont-ils évalués ?\nLes facteurs de risque influencent-ils le traitement ?\nLes facteurs de risque sont-ils notés dans le compte-rendu ?\nComment réduire les facteurs de risque après la sortie ?", "url": "https://questionsmedicales.fr/mesh/D063886?mesh_terms=Early+Detection+of+Cancer&page=1000#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Quels diagnostics sont souvent notés dans un compte-rendu ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Les diagnostics incluent des maladies aiguës, chroniques et des complications post-opératoires." } }, { "@type": "Question", "name": "Comment le diagnostic est-il confirmé dans le rapport ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic est confirmé par des examens cliniques, des tests de laboratoire et des imageries." } }, { "@type": "Question", "name": "Quelle est l'importance du diagnostic dans le compte-rendu ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Il guide le suivi médical et les traitements à administrer après la sortie." } }, { "@type": "Question", "name": "Les diagnostics sont-ils classés dans le compte-rendu ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils sont souvent classés par ordre de gravité ou de chronologie." } }, { "@type": "Question", "name": "Comment les diagnostics influencent-ils le traitement ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Ils déterminent les protocoles de traitement et les médicaments prescrits." } }, { "@type": "Question", "name": "Quels symptômes sont souvent mentionnés ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent douleur, fièvre, fatigue et autres signes cliniques pertinents." } }, { "@type": "Question", "name": "Comment les symptômes sont-ils évalués ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Ils sont évalués par l'examen physique et les antécédents médicaux du patient." } }, { "@type": "Question", "name": "Les symptômes changent-ils après le traitement ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le compte-rendu note souvent l'évolution des symptômes post-traitement." } }, { "@type": "Question", "name": "Les symptômes sont-ils classés par gravité ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent être classés en fonction de leur impact sur la santé du patient." } }, { "@type": "Question", "name": "Comment les symptômes influencent-ils le suivi ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Ils orientent les recommandations de suivi et les consultations nécessaires." } }, { "@type": "Question", "name": "Quelles mesures préventives sont recommandées ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Les mesures incluent vaccinations, conseils diététiques et exercices physiques." } }, { "@type": "Question", "name": "Comment la prévention est-elle abordée dans le rapport ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Elle est abordée par des recommandations spécifiques basées sur le diagnostic." } }, { "@type": "Question", "name": "La prévention est-elle personnalisée ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle est souvent adaptée aux antécédents médicaux et au mode de vie du patient." } }, { "@type": "Question", "name": "Quels conseils de prévention sont souvent inclus ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Des conseils sur l'alimentation, l'exercice et l'arrêt du tabac sont fréquents." } }, { "@type": "Question", "name": "La prévention est-elle suivie après la sortie ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le suivi des mesures préventives est souvent recommandé lors des consultations." } }, { "@type": "Question", "name": "Quels types de traitements sont documentés ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent médications, interventions chirurgicales et thérapies physiques." } }, { "@type": "Question", "name": "Comment les traitements sont-ils justifiés ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Ils sont justifiés par les diagnostics et l'évolution des symptômes du patient." } }, { "@type": "Question", "name": "Les traitements sont-ils suivis d'effets secondaires ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les effets secondaires potentiels sont souvent notés pour chaque traitement." } }, { "@type": "Question", "name": "Comment les traitements sont-ils planifiés ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Ils sont planifiés en fonction des besoins individuels et des protocoles médicaux." } }, { "@type": "Question", "name": "Les traitements sont-ils adaptés après la sortie ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des ajustements peuvent être nécessaires en fonction de l'évolution du patient." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir après la sortie ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent infections, douleurs persistantes et complications liées aux traitements." } }, { "@type": "Question", "name": "Comment les complications sont-elles signalées ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Elles sont signalées par des observations cliniques et des tests de suivi." } }, { "@type": "Question", "name": "Les complications sont-elles documentées dans le rapport ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles sont souvent documentées pour informer le suivi médical." } }, { "@type": "Question", "name": "Comment prévenir les complications après la sortie ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "La prévention passe par des soins appropriés et le respect des recommandations médicales." } }, { "@type": "Question", "name": "Les complications influencent-elles le suivi ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent nécessiter des consultations supplémentaires et des ajustements de traitement." } }, { "@type": "Question", "name": "Quels facteurs de risque sont souvent identifiés ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'âge, les antécédents familiaux et les habitudes de vie." } }, { "@type": "Question", "name": "Comment les facteurs de risque sont-ils évalués ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Ils sont évalués par l'anamnèse et des tests de dépistage spécifiques." } }, { "@type": "Question", "name": "Les facteurs de risque influencent-ils le traitement ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent orienter les choix thérapeutiques et les recommandations de suivi." } }, { "@type": "Question", "name": "Les facteurs de risque sont-ils notés dans le compte-rendu ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils sont souvent notés pour une meilleure gestion des soins futurs." } }, { "@type": "Question", "name": "Comment réduire les facteurs de risque après la sortie ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "La réduction passe par des changements de mode de vie et un suivi médical régulier." } } ] } ] }

Sources (10000 au total)

The role of diffusion magnetic resonance imaging in determining tumor aggressiveness during preoperative surgical planning in early-stage endometrial cancer.

The present study aimed to evaluate the relationship between tumor volume and apparent diffusion coefficient (ADC) in preoperative magnetic resonance imaging and deep myometrial invasion, tumor grade,... The study included 73 patients diagnosed with early-stage endometrial cancer based on histopathological examination between May 2014 and July 2019. Receiver operating characteristic (ROC) curve analys... The areas under the ROC curves (AUCs) of ADC and tumor volume in predicting LVI, DMI, and high tumor grade were significantly greater than those for superficial myometrial invasion and low-grade tumor... In the absence of pathological pelvic lymph nodes in early-stage endometrial cancer, tumor volume in DWI sequences determines the active tumor load and tumor aggressiveness. Furthermore, a low ADC ind...

Survival and prognostic factors of early-stage non-small cell lung cancer in Central and Eastern Europe: A prospective cohort study.

Although early diagnosis and surgical resection of the tumor have been shown to be the most important predictors of lung cancer survival, long-term survival for surgically-resected early-stage lung ca... In this prospective study we aimed to investigate the survival and prognostic factors of surgically-resected early-stage non-small cell lung cancer (NSCLC) in Central and Eastern Europe.... We recruited 2052 patients with stage I-IIIA NSCLC from 9 centers in Russia, Poland, Serbia, Czech Republic, and Romania, between 2007-2016 and followed them annually through 2020.... During follow-up, there were 1121 deaths (including 730 cancer-specific deaths). Median survival time was 4.9 years, and the 5-year overall survival was 49.5%. In the multivariable model, mortality wa... This study shows that the 5-year survival rate of surgically-resected stage I-IIIA NSCLC is still around 50% in Central and Eastern Europe. In addition to non-modifiable prognostic factors, lifetime p...

Immune checkpoints expression patterns in early-stage triple-negative breast cancer predict prognosis and remodel the tumor immune microenvironment.

Currently, targeting immune checkpoint molecules holds great promise for triple-negative breast cancer (TNBC). However, the expression landscape of immune checkpoint genes (ICGs) in TNBC remains large... Herein, we systematically investigated the ICGs expression patterns in 422 TNBC samples. We evaluated the ICGs molecular typing based on the ICGs expression profile and explored the associations betwe... Two ICGs clusters and two ICGs-related gene clusters were determined, which were involved in different survival outcomes, biological roles and infiltration levels of immune cells. We established a qua... Collectively, dissecting the ICGs expression patterns not only provides a new insight into TNBC subtypes but also deepens the understanding of ICGs in the tumor immune microenvironment....

Meta-analysis of laparoscopic radical hysterectomy, excluding robotic assisted versus open radical hysterectomy for early stage cervical cancer.

Recent evidence has shown an increase in recurrence and a decrease in overall survival in patients treated with laparoscopic radical hysterectomy (LRH) and robotic assisted radical hysterectomy (RRH) ...

Initial Experience With Trans-anal Minimally Invasive Surgery (TAMIS) for Rectal Polyps and Early Colorectal Cancers at Cumberland Infirmary, Carlisle.

Bowel cancer is the fourth most common type of cancer in the United Kingdom in 2019. Total mesorectal excision is the standard procedure for the removal of rectal tumors, however, it comes with seriou... During a five-year period, 42 patients underwent TAMIS at Cumberland Infirmary. The primary indication for TAMIS was distal rectal lesions, large rectal polyps up to 120 mm, and early rectal cancer (T... Our findings suggest that TAMIS produces positive results. The size of the lesions removed, and the effect of an early learning curve are reflected in the rate of specimen fragmentation and polyp recu...

Ultrasound contrast-enhanced patterns of sentinel lymph nodes: predictive value for nodal status and metastatic burden in early breast cancer.

In the post-Z0011 era, sentinel lymph node (SLN) status and metastatic burden determine whether axillary management entails conservative sentinel lymph node biopsy (SLNB) or radical axillary lymph nod... A retrospective study was conducted on 88 consecutive patients who were diagnosed with clinical T1-2N0 breast cancer between December 2020 and November 2021 at the Lanzhou University Second Hospital a... CEUS successfully identified at least 1 SLN in 88 patients, with a total of 118 SLNs identified in the entire cohort. Univariate analysis showed that lesion size, blood flow grade, SLN longitudinal di... The contrast-enhanced pattern of the SLN is an independent risk factor for SLN status. Patients presenting with a type I or type II SLN enhanced pattern are unlikely to have high-burden metastases det...

Uniportal robotic-assisted thoracoscopic surgery for early-stage lung cancer with the Da Vinci Xi: Initial experience of two cases.

Minimally invasive surgery (MIS) techniques, currently considered the gold standard in the treatment of early-stage non-small cell lung cancer (NSCLC), are mainly represented by video-assisted thoraco... U-RATS was conducted through a single 4 cm long antero-lateral mini-thoracotomy (ALMT) in the sixth intercostal space at the mid-axillary line. Three 8 mm robotic trocars were positioned and connected... Case 1: an 82-year-old woman (American Society of Anaesthesiologists [ASA III]) underwent a left S6 segmentectomy for a clinical stage IA2 NSCLC, complicated by an air leak that resolved spontaneously... From what emerged in our small series, U-RATS with the Da Vinci Xi surgical system might be considered a safe, reliable, and effective alternative to other MIS techniques. Larger prospective studies a...